Craft

Yongtai Biopharmaceutical

Stock Price

$1.8

2024-10-29

Market Capitalization

$1 B

2024-10-29

Yongtai Biopharmaceutical Summary

Company Summary

Overview
Yongtai Biopharmaceutical is a company that develops and commercializes cell immunotherapy products. It offers cell series and drugs for the treatment of cancer disease.
Type
Public
Status
Active
Founded
2006
HQ
Hong Kong, HK | view all locations
Website
http://www.eaal.net
Cybersecurity rating
Sectors

Key People

  • Tan Zheng

    Tan Zheng, Chairman and Executive Director

    • Wang Yu

      Wang Yu, Executive Director and Chief Executive Officer, Co-Chief Technology Officer

      • Zheng Xuanzhe

        Zheng Xuanzhe, Chief Strategy Officer

        • Zhang Jian

          Zhang Jian, Senior Vice President

          LocationsView all

          2 locations detected

          • Hong Kong, Hong Kong Island HQ

            Hong Kong

            31/F, Times Square Tower 2, 1 Matheson Street

          • Beijing, Beijing

            China

            8th Floor, Building 1, No. 1 Kangding Street, Beijing Economic and Technological Development Zone

          Yongtai Biopharmaceutical Financials

          Summary Financials

          Gross profit (FY, 2025)
          ¥20.0M
          Net income (FY, 2025)
          (¥230.9M)
          Cash (FY, 2025)
          ¥54.5M
          EBIT (FY, 2025)
          (¥155.7M)
          Enterprise value
          $1.4B

          Footer menu